Applied RNA Seq Summit for Drug Discovery & Development 2018
In-Person Event
Apr 24 - 26, 2018
San Francisco, California, USA
OVERVIEW
Applied RNA Seq Summit for Drug Discovery & Development is organized by Hanson Wade and will be held during Apr 24 - 26, 2018 at The Meridien San Francisco, San Francisco, California, United States of America.
Conference Objectives are :
This Conference provides a vital forum for practitioners to come up to speed with the latest advances in RNA-Seq technologies and analytical tools, as well as help devise solutions to key challenges surrounding drug development and clinical applications of RNA-Seq.
Harness the next generation of RNA-Seq methods to find the signal amongst the noise when overcoming the analytical and processing challenges of RNA-Seq data. Deepen your understanding of disease biology through optimized application of RNA-Seq methods, and improve your drug discovery, biomarker and clinical applications as RNA-Seq storms into the clinic. This year's agenda has been designed specifically for the RNA-Seq community by fore-thinkers in the industry with a greater focus on single-cell RNA-Seq, bioinformatics approaches and the clinical applications of RNA-Seq.
What's new to RNA-Seq 2018?
• Discover how BMS are carrying out integrated analysis by co-extraction of RNA, DNA and protein from FFPE Tumour samples.
• Gain new insights into RNA-Seq for the study of viral transcripts, data visualization, gene fusion identification and more from companies such as Genetech, GSK, BMS, Merck, The Mayo Clinic and UCSC Genome Browser.
• Explore new solutions to:
? Roadblocks in applying single cell and other emerging RNA sequencing technologies in the clinic.
? Accurately interpreting the vast amounts of data in unpicking the complexity of the transcriptome.
? Integrating and mining of RNA-Seq data for drug discovery research.
? Novel and innovative RNA-Seq methods to understand the impact of tissue composition and cellular interactions.
Conference Objectives are :
• Understand how to effectively develop RNA-Seq technologies into clinically applicable tools.
• Learn how to leverage single-cell RNA-Seq as a rapid and comprehensive method for target validation and disease understanding.
• Engage in debate with bioinformaticians and biologists to streamline the RNA-Seq process from the bench to the computer.
• Harness the full potential of single-cell RNA-Seq to revolutionize the way we approach disease research.
• Develop analytical strategies to accurately interpret the vast complexity of the transcriptome and efficiently source the most valuable information.
• Learn how to optimise data visualization in your RNA sequencing work.
Additional details will be posted as soon as they are available.
Conference Objectives are :
This Conference provides a vital forum for practitioners to come up to speed with the latest advances in RNA-Seq technologies and analytical tools, as well as help devise solutions to key challenges surrounding drug development and clinical applications of RNA-Seq.
Harness the next generation of RNA-Seq methods to find the signal amongst the noise when overcoming the analytical and processing challenges of RNA-Seq data. Deepen your understanding of disease biology through optimized application of RNA-Seq methods, and improve your drug discovery, biomarker and clinical applications as RNA-Seq storms into the clinic. This year's agenda has been designed specifically for the RNA-Seq community by fore-thinkers in the industry with a greater focus on single-cell RNA-Seq, bioinformatics approaches and the clinical applications of RNA-Seq.
What's new to RNA-Seq 2018?
• Discover how BMS are carrying out integrated analysis by co-extraction of RNA, DNA and protein from FFPE Tumour samples.
• Gain new insights into RNA-Seq for the study of viral transcripts, data visualization, gene fusion identification and more from companies such as Genetech, GSK, BMS, Merck, The Mayo Clinic and UCSC Genome Browser.
• Explore new solutions to:
? Roadblocks in applying single cell and other emerging RNA sequencing technologies in the clinic.
? Accurately interpreting the vast amounts of data in unpicking the complexity of the transcriptome.
? Integrating and mining of RNA-Seq data for drug discovery research.
? Novel and innovative RNA-Seq methods to understand the impact of tissue composition and cellular interactions.
Conference Objectives are :
• Understand how to effectively develop RNA-Seq technologies into clinically applicable tools.
• Learn how to leverage single-cell RNA-Seq as a rapid and comprehensive method for target validation and disease understanding.
• Engage in debate with bioinformaticians and biologists to streamline the RNA-Seq process from the bench to the computer.
• Harness the full potential of single-cell RNA-Seq to revolutionize the way we approach disease research.
• Develop analytical strategies to accurately interpret the vast complexity of the transcriptome and efficiently source the most valuable information.
• Learn how to optimise data visualization in your RNA sequencing work.
Additional details will be posted as soon as they are available.
KEY DATES
24 Apr, 2018
Event Start Date
26 Apr, 2018
Event End Date
SPECIALITIES
BiotechnologyMolecular BiologySUGGESTED HOTELS
CONFERENCE VENUE
The Meridien San Francisco
Quick Links